Several factors have come together to help create the foundation for the biotech startup ecosystem New York City has craved for so long. Early stage life science investors, new startup incubators, and government initiatives have all played a part. And they’ve helped foster a new breed of biotechs in the city, companies with the backing to pursue cutting-edge science and the thirst to prove that life sciences startups spun out of New York research can stay, grow, and thrive in the Big Apple. Their success, or failure, will play a big part in determining the future of the ecosystem. Who are these companies, and how did they come together? Who are the people living their stories, and what challenges have they faced—and overcome—to get as far as they have? partneringONE®: Our partnering platform through EBD Group is the most efficient way to find and meet the right people for your company’s collaborative business needs. Leverage the online system to review attendee profiles and walk into the event with pre-scheduled, one-to-one on-site meetings to accelerate partnerships and deal making! This is a great opportunity for local biotech companies to identify and meet with pharma, investors, and others in the New York region. Learn more.
3:30 – 4:15pm
Registration, Networking, & Partnering
4:15 – 4:20pm
Greg Huang – Editor in Chief, Xconomy
4:20 – 4:50pm
The HiberCell Story
How Mt. Sinai Research and Local Support Spawned an Ambitious Cancer Startup
Alan Rigby – CEO, HiberCell Ari Nowacek – Principal, Arch Venture Partners; Co-founder, HiberCell
4:50 – 5:20pm
The Prevail Therapeutics Story
Can a Top Biotech Investor’s Parkinson’s Diagnosis Lead to a Treatment?